With the emergence and long-term Impact of COVID-19, Global Cephalosporin Drugs Market to reach USD xx billion by 2030
Bizwit Research & Consulting LLP’s recent analysis on the Global Cephalosporin Drugs Market points towards a potential rise to USD xx billion by 2030. Cephalosporin, a versatile β-lactam antibiotic with a broad spectrum, is derived from the fungus Acremonium. It is primarily employed for treating a wide range of bacterial infections, such as skin infections, otitis media, pneumonia, staph infections, tonsillitis, strep throat, bronchitis, and gonorrhea, serving both therapeutic and preventive purposes. First-generation cephalosporins are particularly effective against gram-positive bacteria such as Staphylococcus and Streptococcus, playing a crucial role in preventing hospital-acquired infections and treating skin and soft tissue infections.
In contrast, second to fifth-generation cephalosporin drugs are specifically designed to combat gram-negative bacteria. These medications are also used in managing drug-induced allergic conditions, particularly in individuals with penicillin allergies. The Cephalosporin Drugs Market is expanding because of factors such as the increasing prevalence of infectious diseases, rise in government initiatives and healthcare policies, growing funding for the development of antibiotics, and expanding access to healthcare services.
Geographically, the global Cephalosporin Drugs market has been segmented into North America, Europe, Asia Pacific (APAC), Latin America, and Middle East and Africa (MEA). North America dominated the market in 2022 owing to the escalating infectious disease rates, growing healthcare spending, and a sizable population, availability of advanced healthcare infrastructure and skilled medical professionals. According to the Center for Disease Control and Prevention (CDC), in 2020, the United States recorded approximately 7,174 new tuberculosis cases, reflecting a rate of 2.2 per 100,000 individuals, highlighting a significant concern. Consequently, the mounting burden of infectious diseases is expected to propel market expansion.
Whereas, Asia Pacific is expected to grow at the highest CAGR over the forecast years. The increasing number of surgical procedures, hospitalizations, and healthcare-associated infections, the growing geriatric population, and favorable government initiatives to combat antimicrobial resistance are significantly propelling the market demand across the region.
The global Cephalosporin Drugs market is highly competitive owing to the presence of several key players such as Baxter International Inc. F. Hoffmann-La Roche Ltd GlaxoSmithKline PLC Lupin Pharmaceuticals Inc. Macleods Pharmaceuticals Ltd Mankind Pharma Ltd. Merck & Co. Inc Pfizer Inc. Teva Pharmaceutical Industries Ltd Bristol-Myers Squibb Company, and others.
For further analysis on this or to request a sample copy of this report, please click the link mentioned below:
Key findings of the study suggest:
- Global Cephalosporin Drugs Market is anticipated to grow with a healthy growth rate of more than 2.75% over the forecast period 2023-2030.
- In the Generation segment, Second-generation emerged out as the leading market segment in 2022.
- North America is anticipated to drive regional growth owing to escalating infectious disease rates in the region.
- Asia Pacific is expected to grow at higher rate owing to increasing number of surgical procedures in the region.
Bizwit Research & Consulting has considered following segments for the study:
By Generation:
- First-generation
- Second-generation
- Third-generation
- Fourth-generation
- Fifth-generation
By Prescription:
- Prescription Drugs
- OTC Drugs
Regional Outlook
- North America
- US
- Canada
- Europe
- UK
- Germany
- France
- Spain
- Italy
- ROE
- Asia Pacific
- China
- India
- Japan
- Korea
- Australia
- RoAPAC
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- Saudi Arabia
- South Africa
- Rest of Middle East & Africa
To get a sample of this report or to purchase a copy of the study, you can directly contact us at: sales@bizwitresearch.com
About Us
Bizwit Research & Consulting LLP is a global provider of business intelligence & consulting services. The company has a strong primary base of key industry leaders along with the chain of industry analysts to analyze the market trends and its future impact in order to estimates and forecast different business segments and markets. Bizwit incorporate big data, expert analysis, and huge industry database to deliver client focused business consulting reports. Our analysts perform unbiased measurement and assessment of market opportunities to comprehend detailed market forecast. Our team of key opinion leaders evaluates the market size, growth prospects, end-use, applications, value & supply chain and top vendors in the industry to help the clients to take conversant business decisions without any vague assumptions.
Contact US
Global Business Development
Phone: +1 209 498-3066
Email: Sales@bizwitresearch.com
Website: www.bizwitresearch.com
